GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The hormone progesterone is readily converted to 3alpha-OH-5alpha-pregnan-20-one (3alpha,5alpha-THP) in the brains of males and females. In the brain, 3alpha,5alpha-THP acts like a sedative, decreasing anxiety and reducing seizure activity, by enhancing the function of GABA (gamma-aminobutyric acid), the brain's major inhibitory neurotransmitter. Symptoms of premenstrual syndrome (PMS), such as anxiety and seizure susceptibility, are associated with sharp declines in circulating levels of progesterone and, consequently, of levels of 3alpha,5alpha-THP in the brain. Abrupt discontinuation of use of sedatives such as benzodiazepines and ethanol can also produce PMS-like withdrawal symptoms. Here we report a progesterone-withdrawal paradigm, designed to mimic PMS and post-partum syndrome in a rat model. In this model, withdrawal of progesterone leads to increased seizure susceptibility and insensitivity to benzodiazepine sedatives through an effect on gene transcription. Specifically, this effect was due to reduced levels of 3alpha,5alpha-THP which enhance transcription of the gene encoding the alpha4 subunit of the GABA(A) receptor. We also find that increased susceptibility to seizure after progesferone withdrawal is due to a sixfold decrease in the decay time for GABA currents and consequent decreased inhibitory function. Blockade of the alpha4 gene transcript prevents these withdrawal properties. PMS symptoms may therefore be attributable, in part, to alterations in expressio…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This effect involves a 6-fold decrease in the GABAA current time constant.”
From Fibromyalgia pathogenesis explained by a neuroendocrine multistable model (2024) · cites this paper as [55]
In the citing paper
“In a progesterone-withdrawal paradigm in the rat, mimicking post-menstrual and post-partum syndromes, reduced levels of allopregnanolone enhance the expression of GABAA α4 subunit, involving GABAA reduced activity [55].”
From Fibromyalgia pathogenesis explained by a neuroendocrine multistable model (2024) · cites this paper as [55]
Citations
Cites
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225 · cited 1×
“, decreasing anxiety and reducing seizure activity, by enhancing the function of GABA (γ-aminobutyric acid”
BackgroundPurdy, R. H., Morrow, A. L., Moore, P. H., & Paul, S. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4553 · Cited by 951
Bitran, D., Hilvers, R. J., & Kellogg, C. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90761-j · Cited by 457
Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one
Belelli, D., Bolger, M. B., & Gee, K. W. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90077-0 · Cited by 323
Wafford, K. A., Thompson, S. A., Thomas, D., Sikela, J., Wilcox, A. S., & Whiting, P. J. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09339-3 · Cited by 268
Devaud, L. L., Fritschy, J., Sieghart, W., & Morrow, A. L. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010126.x · Cited by 261
Cloning, pharmacological characteristics and expression pattern of the rat GABAA receptor α4 subunit
Wisden, W., Herb, A., Wieland, H., Keinänen, K., Lüddens, H., & Seeburg, P. H. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81076-k · Cited by 260
Twyman, R. E., & Macdonald, R. L. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019334 · Cited by 243
Bäckström, T., Zetterlund, B., Blom, S., & Romano, M. (1984) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1984.tb07807.x · Cited by 242
The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABAA receptors
Brot, M. D., Akwa, Y., Purdy, R. H., Koob, G. F., & Britton, K. T. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00096-4 · Cited by 234
Research works printed but not linked: 1
- Wafford, K. A. et al. Functional characterization of human GABA receptors containing the α4 subunit. Mol. Pharmacol. 50, 670–678 (1996).
Cited by
Items 401–500 of 561
PR-independent neurosteroid regulation of α2-GABA-A receptors in the hippocampus subfields
Reddy, D. S., Gangisetty, O., & Wu, X. Y. (2017) · Brain Research · doi:10.1016/j.brainres.2017.01.030 · Cited by 18
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript 2000) and hippocampus neurons (Smith et al., 1998a; Gangisetty and Reddy, 2010; Wu et al., 2013).”
BackgroundInfluentialPark, H., Choi, I., Nakamura, M., Cho, J., Lee, M., & Jang, I. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.097 · Cited by 18
“Therefore, altered levels of these neurosteroids in the brain might have a broad effect on some neurological symptoms including depression, premenstrual syndrome, and catamenial epilepsy (Uzunova et al., 1998; Smith et al., 1998; Reddy et al., 2001).”
BackgroundPeng, Z., Zhang, N., Chandra, D., Homanics, G. E., Olsen, R. W., & Houser, C. R. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1202-1 · Cited by 17
“As discussed previously, a marked increase in a4 subunit expression is observed in a number of conditions, including withdrawal from progesterone [12], chronic administration of ethanol [15, 67], and multiple models of epilepsy [3, 17, 18].”
Clossen, B. L., & Reddy, D. S. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24028 · Cited by 17
Schindler, C. J., Šlamberová, R., & Vathy, I. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00027-6 · Cited by 16
Neurosteroids Exhibit Differential Effects on mIPSCs Recorded From Normal and Seizure Prone Rats
Schwabe, K., Gavrilovici, C., McIntyre, D., & Poulter, M. O. (2005) · Journal of Neurophysiology · doi:10.1152/jn.01233.2004 · Cited by 17
“In particular the “crash” in progesterone plasma concentrations after parturition has been implicated in increased susceptibility to druginduced seizures (Smith et al. 1998a,b).”
BackgroundEffects of a low dose of ethanol in an animal model of premenstrual anxiety
Smith, S. S., Ruderman, Y., Gong, Q. H., & Gulinello, M. E. (2004) · Alcohol · doi:10.1016/j.alcohol.2004.04.003 · Cited by 18
“Animals are subsequently tested 24 h after discontinuation of the steroid during a “withdrawal” syndrome of increased anxiety and behavioral reactivity produced by declining levels of 3α,5α-THP (Smith et al., 1998a, 1998b).”
BackgroundInfluentialSelf-citationCan animal models resemble a premenstrual dysphoric condition?
Estrada-Camarena, E. M., & López‐Rubalcava, C. (2022) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2022.101007 · Cited by 17
Islas-Preciado, D., López‐Rubalcava, C., Gonzalez-Olvera, J. J., Gallardo-Tenorio, A., & Estrada-Camarena, E. M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.08.050 · Cited by 17
Sekine, S., Matsumoto, S., Isshiki, A., Kitamura, T., Yamada, J., & Watanabe, Y. (2006) · Neurochemical Research · doi:10.1007/s11064-005-9024-4 · Cited by 16
“GABAA receptor have been found to be insensitive to modulation by diazepam and classical BZ agents [3, 10, 14, 15, 18, 19], whereas they are highly sensitive to modulation”
BackgroundPillai, G. V., Smith, A. J., Hunt, P. A., & Simpson, P. B. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.013 · Cited by 15
Smith, S. S., & Gong, Q. H. (2007) · Alcohol · doi:10.1016/j.alcohol.2007.04.007 · Cited by 16
“…indeed a target for low dose ethanol is provided by the high sensitivity of native α4βδ GABAR (Sundstrom-Poromaa et al., 2002), which increase expression following withdrawal from the GABA-modulatory steroid THP (3α-OH-5βpregnan-20-one), in a rat model of premenstrual syndrome (Smith et al., 1998).”
BackgroundMethodSelf-citationPremenstrual syndromes: closing the 20th century chapters
Halbreich, U. M. (1999) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-199906000-00006 · Cited by 18
Fibromyalgia pathogenesis explained by a neuroendocrine multistable model
Demori, I., Losacco, S., Giordano, G., Mucci, V., Blanchini, F., & Burlando, B. (2024) · PLOS ONE · doi:10.1371/journal.pone.0303573 · Cited by 14
Steroid requirements for regulation of the α4 subunit of the GABAA receptor in an in vitro model
Zhou, X., & Smith, S. S. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.10.018 · Cited by 15
Self-citationChronic Intermittent Ethanol Regulates Hippocampal GABA(A) Receptor Delta Subunit Gene Expression
Follesa, P., Floris, G., Asuni, G. P., Ibba, A., Tocco, M. G., Zicca, L., Mercante, B., Deriu, F., & Gorini, G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00445 · Cited by 15
“Notably, hippocampal overexpression of the α4 subunit has been associated with increased anxiety (Smith et al., 1998a), which is thought to contribute to increased vulnerability to EtOH abuse.”
BackgroundGlycine and GABAA Ultra-Sensitive Ethanol Receptors as Novel Tools for Alcohol and Brain Research
Naito, A., Muchhala, K. H., Asatryan, L., Trudell, J. R., Homanics, G. E., Perkins, D. I., Davies, D. L., & Alkana, R. L. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.093773 · Cited by 15
“…WT (Table 1). g2 and a1 GABAAR USERs do not have altered sensitivity to the neurosteroid Allopregnanolone (3a,5a-THP) Allopregnanolone is an active metabolite of progesterone, and selectively enhances GABAA receptor function (Turner and Simmonds, 1989; Smith et al., 1998; Evers et al., 2010).”
BackgroundSoares-Rachetti, V. D. P., Pinto, Í. A. D. S., Santos, R. O., Andrè, E., Gavioli, E. C., & Lovick, T. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636106 · Cited by 16
“A similar withdrawal response also occurs in the PAG and several other brain regions, when progesterone concentration is allowed to fall rapidly after several days’ repeated dosing with exogenous progesterone (Griffiths and Lovick, 2005a; Reddy et al., 2012; Smith et al., 1998a).”
BackgroundSchacht, J. P., Randall, P. K., Waid, L. R., Baros, A. M., Latham, P. K., Wright, T. M., Myrick, H., & Anton, R. F. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01554.x · Cited by 15
“…et al., 2003; Kumari & Ticku, 2000), and causes GABAA receptors to shift their composition to contain more α4 subunits, a formation that is less responsive to GABA signaling (Biggio et al., 2007; Sanna et al., 2003) and is associated with increased withdrawal-induced anxiety (Smith et al., 1998).”
BackgroundNeurosteroid Replacement Therapy for Catamenial Epilepsy
Reddy, D. S., & Rogawski, M. A. (2010) · Epilepsy · doi:10.1201/9781420085594-c28 · Cited by 14
Perimenstrual Catamenial Epilepsy
Reddy, D. (2007) · Women's Health · doi:10.2217/17455057.3.2.195 · Cited by 13
“This suggests that an abrupt withdrawal of allopregnanolone at the onset of menstruation could decrease inhibitory effect and possibly exacerbate seizures [29,30].”
BackgroundPotentiation of GABAergic Neurotransmission by Steroids
Purdy, R. H., & Paul, S. M. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-693-5_8 · Cited by 14
The Paradox of the Paroxysm: Can Seizure Precipitants Help Explain Human Ictogenesis?
Huberfeld, G., Duigou, C. L., Quyen, M. L. V., Navarro, V., Baulac, M., & Miles, R. (2013) · The Neuroscientist · doi:10.1177/1073858413497430 · Cited by 15
Arbo, B. D., Goveia, S. D. A., Osterkamp, G., Gomez, R., & Ribeiro, M. F. M. (2013) · Endocrine · doi:10.1007/s12020-013-0126-5 · Cited by 15
“been shown to be effective in increasing the expression of the GABA(A) receptor a4 subunit in the hippocampus of rats [31].”
BackgroundCasasola, C. D., Bargas, J., Arias‐Montaño, J., Calixto, E., Montiel, T., Galarraga, E., & Brailowsky, S. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(01)00314-x · Cited by 13
GABAergic Neuroactive Steroids Modulate Selective Ethanol Actions: Mechanisms and Significance
McDaniel, J. R., Tokunaga, S., Matthews, D. B., Khisti, R. T., & Morrow, A. L. (2003) · Frontiers in neuroscience · doi:10.1201/9780203508169.ch10 · Cited by 13
Female ovarian steroids in epilepsy: A cause or remedy
Alam, M. N., Ahmad, A., Al-Abbasi, F. A., & Ahmad, A. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71061-2 · Cited by 13
What is special about the adolescent (JME) brain?
Craiu, D. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.12.008 · Cited by 12
Alternative splicing of the GABAA receptor α4 subunit creates a severely truncated mRNA
Mu, W., Cheng, Q., Yang, J., & Burt, D. R. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(02)00816-x · Cited by 15
Babalonis, S. L., Lile, J. A., Martin, C. A., & Kelly, T. H. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2206-7 · Cited by 13
“During the mid-luteal phase, levels of progesterone and its metabolites are elevated for several days, which causes changes in GABAA receptor sensitivity (Smith et al. 1998; Grobin and Morrow 2000; Rupprecht 2003).”
Insulin sensitivity and premenstrual syndrome
Trout, K. K., & Teff, K. L. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0079-4 · Cited by 14
Oberto, A., Serra, M., Pisu, M. G., Biggio, G., & Eva, C. E. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01079.x · Cited by 13
Islas-Preciado, D., Ugalde-Fuentes, G., Sollozo-Dupont, I., González-Trujano, M. E., Cervantes-Anaya, N., Estrada-Camarena, E. M., & López‐Rubalcava, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137259 · Cited by 11
Chapter 3 Short-term modulation of GABAA receptor function in the adult female rat
Brussaard, A. B., & Koksma, J.-J. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)39005-8 · Cited by 11
Estrogen and Progesterone Receptors
Allan, G. F. (2001) · Elsevier eBooks · doi:10.1016/b978-012146160-7/50004-4 · Cited by 11
Tóth, M., & Zupan, B. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn023 · Cited by 12
Female sex steroids and epilepsy: Part 2. A practical and human focus on catamenial epilepsy
Alshakhouri, M., Sharpe, C. M., Bergin, P., & Sumner, R. L. (2023) · Epilepsia · doi:10.1111/epi.17820 · Cited by 10
Approche GABAergique de la dépression du post-partum : une revue critique translationnelle
Verbe, J., Dubertret, C., El‐Hage, W., Bonnet‐Brilhault, F., & Duriez, P. (2019) · L Encéphale · doi:10.1016/j.encep.2019.09.007 · Cited by 13
Bell, E. C., Baker, G. B., Poag, C., Bellavance, F., Khudabux, J., & Mellédo, J. L. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1660-2 · Cited by 10
Plasticity of the α4βδ GABAA receptor
Shen, H., & Smith, S. S. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371378 · Cited by 10
Self-citationZhou, X., & Smith, S. S. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.02.009 · Cited by 11
“For both THP and ethanol, at least one population of these receptors was of the α4βγ2 subtype (Cagetti et al., 2003; Smith et al., 1998; Liang et al., 2007), based on the distinctive pharmacology of this receptor isoform (Wafford et al., 1996).”
BackgroundMethodResultSelf-citationCharacterization of neurosteroid effects on hyperpolarizing current at α4β2δ GABAA receptors
Gong, Q. H., & Smith, S. S. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3538-x · Cited by 11
Self-citationKavaliers, M., Wiebe, J. P., & Ossenkopp, K. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00835-0 · Cited by 10
Subcellular localization and regulation of GABAA receptors and associated proteins
Lüscher, B., & Fritschy, J. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)48013-5 · Cited by 10
Withdrawal Effects of a Neuroactive Steroid as a Model of PMS: Synaptic Physiology to Behavior
Smith, S. S. (2003) · Frontiers in neuroscience · doi:10.1201/9780203508169.ch7 · Cited by 11
Self-citationZhao, T.-J., Li, M., Chiu, T. H., & Rosenberg, H. C. (1998) · PubMed · Cited by 10
A theory of the anxiolytic action of flumazenil in anxiety disorders
Gallo, A. T., & Hulse, G. K. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221082466 · Cited by 10
“Studies have suggested that flumazenil changes its action from an antagonist to a positive allosteric modulator in some α4containing GABAA receptors (Gangisetty and Reddy, 2010; Smith et al., 1998; Whittemore et al., 1996).”
BackgroundHenderson, L. P., & Jorge, J. C. (2004) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(03)32010-7 · Cited by 17
GABAA receptor α4 subunit in DBA/2J and C57BL/6J mice
Cestari, I. N., Liu, Z. F., Mu, W., & Burt, D. R. (1998) · Brain Research Bulletin · doi:10.1016/s0361-9230(98)00134-8 · Cited by 9
Regulation of cyclic AMP level by progesterone in ovariectomized rat neocortex
Al‐Dahan, M. I., Tehrani, M. H. J., & Thalmann, R. H. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01222-6 · Cited by 9
Pubertal hormones increase hippocampal expression of α4βδ GABAA receptors
Keating, N., Zeak, N., & Smith, S. S. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.02.005 · Cited by 10
Self-citationRahman, M., Borra, V. B., Isaksson, M., Johansson, I., Ragagnin, G., Bäckström, T. C., & Wang, M. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04946.x · Cited by 8
Bitran, D., & Solano, S. M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2194-6 · Cited by 8
“…progesterone or allopregnanolone administration, an anxiogenic-like response is observed during shortterm but continued progesterone treatment (Gulinello et al. 2001; Gulinello and Smith 2003), and by withdrawal from long-term progesterone exposure (Smith et al. 1998a,b; Gulinello et al. 2002).”
Influentialα-Subunit selective modulators of GABAAreceptor function as CNS therapeutics
Hamilton, N. M., & Cooke, A. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.10.1491 · Cited by 8
“Indeed, animal models of epilepsy have lead to changes in the expression of α4 subunit protein and mRNA and elevated levels of α4 subunits are also implicated in animal models of alcohol dependance and in steroid-withdrawal models of premenstrual syndrome [41,42].”
BackgroundClinical implications of circulating neurosteroids
Genazzani, A. R., Monteleone, P., Stomati, M., Bernardi, F., Cobellis, L., Cosarosa, E., Luisi, M., Luisi, S. V., & Petraglia, F. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)46070-3 · Cited by 8
Ye, G., Huang, W., Chen, Z., Zhong, H., Zhong, J., Guo, X., Huang, Y., Kandalai, S., Zhou, X., Zhang, N., et al. (2022) · ChemBioChem · doi:10.1002/cbic.202200473 · Cited by 7
Schumacher, M., & Guennoun, R. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00046-2 · Cited by 9
GABAA receptors as novel drug targets for treatment of mental disorders
Esmaeili, A., & Ghaedi, K. (2010) · Archives of Advances in Biosciences · doi:10.22037/jps.v1i3.1819 · Cited by 7
“to Zn 2+ compared to subunit receptors [57].”
Pre-menstrual Dysphoric Disorder: A Review
Dahuja, M., & Agarwal, S. (2019) · Journal of Psychosexual Health · doi:10.1177/2631831818824439 · Cited by 8
Neurosteroids and the Nervous System
King, S. R. (2012) · SpringerBriefs in neuroscience · doi:10.1007/978-1-4614-5559-2_1 · Cited by 8
Neuroactive Steroids in Anxiety and Stress
Finn, D. A., & Purdy, R. H. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn026 · Cited by 7
Menstrually-related mood disorders and postpartum depression: Convergent aspects in aetiology
Islas-Preciado, D., Estrada-Camarena, E. M., & Galea, L. A. M. (2024) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2024.101171 · Cited by 12
Isoallopregnanolone Inhibits Estrus Cycle-Dependent Aggressive Behavior
Bäckström, T. C., Bengtsson, S. K. S., Sjöstedt, J., Malinina, E., Johansson, M., Ragagnin, G., Ekberg, K., & Lundgren, P. (2023) · Biomolecules · doi:10.3390/biom13061017 · Cited by 6
Kushner, S. A., & Guzé, B. H. (2005) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2005.02.005 · Cited by 6
A New Look at the 5á-Reductase Inhibitor Finasteride
Finn, D. A., Beadles-Bohling, A. S., Beckley, E. H., Ford, M. M., Gililland, K. R., Gorin-Meyer, R. E., & Wiren, K. M. (2006) · Cited by 6
Smith, S. S., & Gong, Q. H. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.03.010 · Cited by 6
Self-citationMalatyńska, E. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.4.309 · Cited by 6
“The decrease of specific subunit mRNA or protein level of the GABA A receptors was demonstrated for α1, 4, 6, γ2 subunits (Brussaard and Baker, 1995; Karle et al., 1995; Zhu et al., 1996; Smith et al., 1998; Zhao et al., 1998).”
BackgroundEstrogen Effects on Hippocampal Synapses
Milner, T. A., McEwen, B. S., & Waters, E. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418675-0.00007-9 · Cited by 5
ffrench-Mullen, J. M. H. (1999) · Steroids · doi:10.1016/s0039-128x(98)00098-1 · Cited by 5
Self-citationPremenstrual Dysphoric Disorder
Poromaa, I. S. (2003) · Frontiers in neuroscience · doi:10.1201/9780203508169.ch13 · Cited by 5
Modulators of the GABAA receptor: Novel therapeutic prospects
Thomsen, C., & Ebert, B. (2001) · Pharmaceutical science series · doi:10.1201/9780203299388.ch18 · Cited by 5
Molecular and Functional Changes in Receptors
Spigelman, I., Olsen, R. W., Liang, J., Suryanarayanan, A., Lindemeyer, A. K., Meyer, E. M., Shen, Y., Bagnera, R. E., & Marty, V. N. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398335-0.00023-6 · Cited by 4
Shorvon, S. D., Andermann, F., & Guerrini, R. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511921001.090 · Cited by 4
Gonadal Hormones and Behavior in Women: Concentrations versus Context
Rubinow, D. R., Schmidt, P. J., Meltzer-Brody, S. E., & Harsh, V. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00076-0 · Cited by 5
Lambert, J. J., & Belelli, D. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704796 · Cited by 5
“Withdrawal from neuro- steroids, (i.e. mimicking changes that occur during the menstrual cycle and pregnancy), causes an upregulation of the a4 subunit, with concomitant changes in hippocampal GABAA receptors (Smith et al., 1998).”
BackgroundHerzog, A. G. (2009) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000300023.30532.d3 · Cited by 4
Sex-Steroid Hormones in Women with Epilepsy
Jetté, N., & Morrell, M. J. (2005) · American Journal of Electroneurodiagnostic Technology · doi:10.1080/1086508x.2005.11079506 · Cited by 4
Impact of Sex Steroids on the Stress Response and Welfare in Female Farm Ruminants
Freitas‐de‐Melo, A., & Ungerfeld, R. (2022) · Sustainable agriculture reviews · doi:10.1007/978-3-031-07496-7_1 · Cited by 5
Gallo, A. T., Addis, S., Martyn, V., Ramanathan, H., Wilkerson, G. K., Bennett, K., Hood, S. D., Stampfer, H. G., & Hulse, G. K. (2023) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253231156400 · Cited by 4
Novel Effects of Neuroactive Steroids in the Central Nervous System
Smith, S. S. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50058-5 · Cited by 3
Self-citationExperimental models for the study of hormonal changes in epilepsy
Taubøll, E., Heuser, K., Sveberg, L., & Svalheim, S. (2015) · Clinical Epileptology · doi:10.1007/s10309-015-0001-x · Cited by 3
Kosonsiriluk, S., Chaiworakul, V., Mauro, L. J., & Halawani, M. E. E. (2016) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2016.04.003 · Cited by 3
Subunit Specificity of Steroid Modulation of GABAA Receptors
Cagetti, E., Olsen, R. W., & Wallner, M. (2003) · Frontiers in neuroscience · doi:10.1201/9780203508169.ch2 · Cited by 3
Neuroactive Steroids: Effects on Cognitive Functions
Bückström, T., Birzniece, V., Fernández, G., Johansson, I., Kask, K., Lindblad, C., Lundgren, P., Nyberg, S., Ragagnin, G., Poromaa, I. S., et al. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6854-6_5 · Cited by 5
Gonadal Hormones and Behavior in Women
Rubinow, D. R., Schmidt, P. J., Roca, C. A., & Daly, R. C. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50086-x · Cited by 3
HORMONES AND GENDER | Hormones and Epilepsy
Woolley, C. S. (2009) · Elsevier eBooks · doi:10.1016/b978-012373961-2.00217-4 · Cited by 3
Therapeutic potential of steroids for CNS disorders
Hamilton, N. M. (2001) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.11.10.1523 · Cited by 3
“This finding is consistent with enhanced transcription of the gene encoding the α4 subunit of the GABAA receptor, which in turn is a result of withdrawal of neurosteroid 15 [24].”
ResultEffects of Allopregnanolone on the EEG of Alcohol-Preferring and Alcohol-Nonpreferring Rats
Slawecki, C. J., Purdy, R. H., Tk, L., Walpole, T., & Ehlers, C. L. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200009000-00007 · Cited by 3
Hormones, monoamines and peripartum affective symptoms
Doornbos, B. (2009) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 5
Bang‐Andersen, B., Olsen, C. K., & Sánchez, C. (2016) · Wiley eBooks · doi:10.1002/9783527800315.ch9 · Cited by 4
Gerbatin, R., Augusto, J., Boutouil, H., Reschke, C., & Henshall, D. (2021) · bioRxiv · doi:10.1101/2021.08.27.457904 · Cited by 3
Andersson, L. (2004) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 5
Babalonis, S. L., Lile, J. A., Martin, C. A., & Kelly, T. H. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328349fc02 · Cited by 2
“This cycle-related chronic exposure to neurosteroids might engender a genomicbased sensitivity to benzodiazepines (Smith et al., 1998), which could have influenced the mid-luteal phase enhancement of the discriminative stimulus effects of triazolam.”
BackgroundEmerging evidence for pregnane steroid therapeutics for alcohol use disorders
Morrow, A. L., McFarland, M. H., O’Buckley, T. K., & Robinson, D. L. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.07.004 · Cited by 2
di Michele, F., Caltagirone, C., & Spalletta, G. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6854-6_16 · Cited by 3
Seizing an opportunity: broader definitions of epilepsy may lead to better treatments.
Scharfman, H. E. (2010) · PubMed Central · Cited by 2
Neurosteroid Biosynthesis Upregulation: A Novel Promising Therapy for Anxiety Disorders and PTSD
Pinna, G. (2011) · InTech eBooks · doi:10.5772/18472 · Cited by 2
Pisu, M. G., Floris, I., Maciocco, E., Serra, M., & Biggio, G. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.07.011 · Cited by 2
Huiyun, Z., Wei, S., Sun, P., Xue, L., & Mingqi, Q. (2010) · World Science and Technology · doi:10.1016/s1876-3553(11)60005-7 · Cited by 2
Kesmodel, U. S., Bertrand, J., Støvring, H., Skarpness, B., Denny, C. H., Mortensen, E. L., Bakketeig, L. S., Boyle, C. A., Cogswell, M. E., Eriksen, H. F., et al. (2012) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2012.01435_1.x · Cited by 2
“However, direct measures of GABAergic activity in humans are for evident reasons not easily performed, and much work has been done in animal models (Smith et al., 1998b; Gulinello et al., 2001; Lovick et al., 2005; Maguire et al., 2005; Mostallino et al., 2006; Smith et al., 2006; Maguire and Mody,…”
BackgroundMethodInfluential
Metadata
- Authors
- Smith, S. S., Gong, Q. H., Hsu, F.-C., Markowitz, R. S., ffrench-Mullen, J. M. H., & Li, X.
- Corresponding author
- Smith, Sheryl S.
- ORCID
- Smith, Sheryl S.
- Venue
- Nature
- Published
- 1998-04
- Volume
- 392
- Issue
- 6679
- Pages
- 926-929
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1647312149
- Semantic Scholar
- 3539e8269bee3fd116e338cc540f9de8e78942b1
- Cited by
- 564
- References
- 31
- Citations by year
- 2026: 1 · 2024: 6 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 6 · 2019: 8 · 2018: 3 · 2017: 7 · 2016: 16 · 2015: 14 · 2014: 16 · 2013: 21 · 2012: 20
- FWCI
- 17.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- progesterone withdrawal, 3alpha,5alpha-THP, premenstrual syndrome, seizure susceptibility, GABA currents, gene transcription, steroid hormones, anxiety, GABAergic inhibition
- MeSH terms
- Animals, Azides, Benzodiazepines, Carbolines, Female, gamma-Aminobutyric Acid, Hippocampus, Indomethacin, Lorazepam, Pregnanolone, Premenstrual Syndrome, Progesterone, Receptors, GABA-A, RNA, Messenger, Anti-Anxiety Agents, Transcription, Genetic, Oligonucleotides, Antisense, Pyramidal Cells, Patch-Clamp Techniques, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.